Global Mesalamine Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Mesalamine market size is predicted to grow from US$ 182 million in 2025 to US$ 228 million in 2031; it is expected to grow at a CAGR of 3.8% from 2025 to 2031.
Mesalamine also known as mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.
The global prevalence of IBD is rising, particularly in developed regions like North America and Europe, and increasingly in developing nations such as China and India. This increase is largely attributed to changes in lifestyle, dietary habits, and environmental factors, which are contributing to the growing demand for mesalazine.
With ulcerative colitis being the primary indication for mesalazine, the growing number of patients with this condition is directly driving market demand.
Global key players of Mesalamine are Syntese A/S, PharmaZell and Cambrex Corporation etc. The top 3 companies hold a share over 50%. The global Mesalamine are mainly produced in Europe and United States, they occupied for a share over 60%. Europe is the largest market, has a share about 43%, followed by Asia Pacific and North America, with share 31% and 12%, separately.
LP Information, Inc. (LPI) ' newest research report, the “Mesalamine Industry Forecast” looks at past sales and reviews total world Mesalamine sales in 2024, providing a comprehensive analysis by region and market sector of projected Mesalamine sales for 2025 through 2031. With Mesalamine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mesalamine industry.
This Insight Report provides a comprehensive analysis of the global Mesalamine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mesalamine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Mesalamine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mesalamine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mesalamine.
This report presents a comprehensive overview, market shares, and growth opportunities of Mesalamine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Mesalamine market?
What factors are driving Mesalamine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mesalamine market opportunities vary by end market size?
How does Mesalamine break out by Type, by Application?
The global Mesalamine market size is predicted to grow from US$ 182 million in 2025 to US$ 228 million in 2031; it is expected to grow at a CAGR of 3.8% from 2025 to 2031.
Mesalamine also known as mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.
The global prevalence of IBD is rising, particularly in developed regions like North America and Europe, and increasingly in developing nations such as China and India. This increase is largely attributed to changes in lifestyle, dietary habits, and environmental factors, which are contributing to the growing demand for mesalazine.
With ulcerative colitis being the primary indication for mesalazine, the growing number of patients with this condition is directly driving market demand.
Global key players of Mesalamine are Syntese A/S, PharmaZell and Cambrex Corporation etc. The top 3 companies hold a share over 50%. The global Mesalamine are mainly produced in Europe and United States, they occupied for a share over 60%. Europe is the largest market, has a share about 43%, followed by Asia Pacific and North America, with share 31% and 12%, separately.
LP Information, Inc. (LPI) ' newest research report, the “Mesalamine Industry Forecast” looks at past sales and reviews total world Mesalamine sales in 2024, providing a comprehensive analysis by region and market sector of projected Mesalamine sales for 2025 through 2031. With Mesalamine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mesalamine industry.
This Insight Report provides a comprehensive analysis of the global Mesalamine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mesalamine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Mesalamine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mesalamine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mesalamine.
This report presents a comprehensive overview, market shares, and growth opportunities of Mesalamine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Purity ? 97%
- Purity ? 98%
- Purity ? 99%
- Tablets
- Capsules
- Granule
- Suppository
- Enema
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- PharmaZell
- Syntese A/S
- Cambrex Corporation
- Divis Laboratories
- Chemi SpA
- Ipca Laboratories
- Hangzhou Brother
- Lianyungang Fengheng Biopharm
- Lasa Loboratory
- Corden Pharma Bergamo
- Erregierre SpA
- CTX Lifescience
- Ishita Active Pharma Ingredients
- YC Biotech (Jiangsu)
- Xinxiang Tianfeng Fine Chemical
What is the 10-year outlook for the global Mesalamine market?
What factors are driving Mesalamine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mesalamine market opportunities vary by end market size?
How does Mesalamine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Mesalamine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Mesalamine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Mesalamine by Country/Region, 2020, 2024 & 2031
2.2 Mesalamine Segment by Type
2.2.1 Purity ? 97%
2.2.2 Purity ? 98%
2.2.3 Purity ? 99%
2.3 Mesalamine Sales by Type
2.3.1 Global Mesalamine Sales Market Share by Type (2020-2025)
2.3.2 Global Mesalamine Revenue and Market Share by Type (2020-2025)
2.3.3 Global Mesalamine Sale Price by Type (2020-2025)
2.4 Mesalamine Segment by Application
2.4.1 Tablets
2.4.2 Capsules
2.4.3 Granule
2.4.4 Suppository
2.4.5 Enema
2.4.6 Others
2.5 Mesalamine Sales by Application
2.5.1 Global Mesalamine Sale Market Share by Application (2020-2025)
2.5.2 Global Mesalamine Revenue and Market Share by Application (2020-2025)
2.5.3 Global Mesalamine Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Mesalamine Breakdown Data by Company
3.1.1 Global Mesalamine Annual Sales by Company (2020-2025)
3.1.2 Global Mesalamine Sales Market Share by Company (2020-2025)
3.2 Global Mesalamine Annual Revenue by Company (2020-2025)
3.2.1 Global Mesalamine Revenue by Company (2020-2025)
3.2.2 Global Mesalamine Revenue Market Share by Company (2020-2025)
3.3 Global Mesalamine Sale Price by Company
3.4 Key Manufacturers Mesalamine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mesalamine Product Location Distribution
3.4.2 Players Mesalamine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MESALAMINE BY GEOGRAPHIC REGION
4.1 World Historic Mesalamine Market Size by Geographic Region (2020-2025)
4.1.1 Global Mesalamine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Mesalamine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Mesalamine Market Size by Country/Region (2020-2025)
4.2.1 Global Mesalamine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Mesalamine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Mesalamine Sales Growth
4.4 APAC Mesalamine Sales Growth
4.5 Europe Mesalamine Sales Growth
4.6 Middle East & Africa Mesalamine Sales Growth
5 AMERICAS
5.1 Americas Mesalamine Sales by Country
5.1.1 Americas Mesalamine Sales by Country (2020-2025)
5.1.2 Americas Mesalamine Revenue by Country (2020-2025)
5.2 Americas Mesalamine Sales by Type (2020-2025)
5.3 Americas Mesalamine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mesalamine Sales by Region
6.1.1 APAC Mesalamine Sales by Region (2020-2025)
6.1.2 APAC Mesalamine Revenue by Region (2020-2025)
6.2 APAC Mesalamine Sales by Type (2020-2025)
6.3 APAC Mesalamine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Mesalamine by Country
7.1.1 Europe Mesalamine Sales by Country (2020-2025)
7.1.2 Europe Mesalamine Revenue by Country (2020-2025)
7.2 Europe Mesalamine Sales by Type (2020-2025)
7.3 Europe Mesalamine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Mesalamine by Country
8.1.1 Middle East & Africa Mesalamine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Mesalamine Revenue by Country (2020-2025)
8.2 Middle East & Africa Mesalamine Sales by Type (2020-2025)
8.3 Middle East & Africa Mesalamine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mesalamine
10.3 Manufacturing Process Analysis of Mesalamine
10.4 Industry Chain Structure of Mesalamine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mesalamine Distributors
11.3 Mesalamine Customer
12 WORLD FORECAST REVIEW FOR MESALAMINE BY GEOGRAPHIC REGION
12.1 Global Mesalamine Market Size Forecast by Region
12.1.1 Global Mesalamine Forecast by Region (2026-2031)
12.1.2 Global Mesalamine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Mesalamine Forecast by Type (2026-2031)
12.7 Global Mesalamine Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 PharmaZell
13.1.1 PharmaZell Company Information
13.1.2 PharmaZell Mesalamine Product Portfolios and Specifications
13.1.3 PharmaZell Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 PharmaZell Main Business Overview
13.1.5 PharmaZell Latest Developments
13.2 Syntese A/S
13.2.1 Syntese A/S Company Information
13.2.2 Syntese A/S Mesalamine Product Portfolios and Specifications
13.2.3 Syntese A/S Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Syntese A/S Main Business Overview
13.2.5 Syntese A/S Latest Developments
13.3 Cambrex Corporation
13.3.1 Cambrex Corporation Company Information
13.3.2 Cambrex Corporation Mesalamine Product Portfolios and Specifications
13.3.3 Cambrex Corporation Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Cambrex Corporation Main Business Overview
13.3.5 Cambrex Corporation Latest Developments
13.4 Divis Laboratories
13.4.1 Divis Laboratories Company Information
13.4.2 Divis Laboratories Mesalamine Product Portfolios and Specifications
13.4.3 Divis Laboratories Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Divis Laboratories Main Business Overview
13.4.5 Divis Laboratories Latest Developments
13.5 Chemi SpA
13.5.1 Chemi SpA Company Information
13.5.2 Chemi SpA Mesalamine Product Portfolios and Specifications
13.5.3 Chemi SpA Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Chemi SpA Main Business Overview
13.5.5 Chemi SpA Latest Developments
13.6 Ipca Laboratories
13.6.1 Ipca Laboratories Company Information
13.6.2 Ipca Laboratories Mesalamine Product Portfolios and Specifications
13.6.3 Ipca Laboratories Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Ipca Laboratories Main Business Overview
13.6.5 Ipca Laboratories Latest Developments
13.7 Hangzhou Brother
13.7.1 Hangzhou Brother Company Information
13.7.2 Hangzhou Brother Mesalamine Product Portfolios and Specifications
13.7.3 Hangzhou Brother Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Hangzhou Brother Main Business Overview
13.7.5 Hangzhou Brother Latest Developments
13.8 Lianyungang Fengheng Biopharm
13.8.1 Lianyungang Fengheng Biopharm Company Information
13.8.2 Lianyungang Fengheng Biopharm Mesalamine Product Portfolios and Specifications
13.8.3 Lianyungang Fengheng Biopharm Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Lianyungang Fengheng Biopharm Main Business Overview
13.8.5 Lianyungang Fengheng Biopharm Latest Developments
13.9 Lasa Loboratory
13.9.1 Lasa Loboratory Company Information
13.9.2 Lasa Loboratory Mesalamine Product Portfolios and Specifications
13.9.3 Lasa Loboratory Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Lasa Loboratory Main Business Overview
13.9.5 Lasa Loboratory Latest Developments
13.10 Corden Pharma Bergamo
13.10.1 Corden Pharma Bergamo Company Information
13.10.2 Corden Pharma Bergamo Mesalamine Product Portfolios and Specifications
13.10.3 Corden Pharma Bergamo Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Corden Pharma Bergamo Main Business Overview
13.10.5 Corden Pharma Bergamo Latest Developments
13.11 Erregierre SpA
13.11.1 Erregierre SpA Company Information
13.11.2 Erregierre SpA Mesalamine Product Portfolios and Specifications
13.11.3 Erregierre SpA Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Erregierre SpA Main Business Overview
13.11.5 Erregierre SpA Latest Developments
13.12 CTX Lifescience
13.12.1 CTX Lifescience Company Information
13.12.2 CTX Lifescience Mesalamine Product Portfolios and Specifications
13.12.3 CTX Lifescience Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 CTX Lifescience Main Business Overview
13.12.5 CTX Lifescience Latest Developments
13.13 Ishita Active Pharma Ingredients
13.13.1 Ishita Active Pharma Ingredients Company Information
13.13.2 Ishita Active Pharma Ingredients Mesalamine Product Portfolios and Specifications
13.13.3 Ishita Active Pharma Ingredients Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Ishita Active Pharma Ingredients Main Business Overview
13.13.5 Ishita Active Pharma Ingredients Latest Developments
13.14 YC Biotech (Jiangsu)
13.14.1 YC Biotech (Jiangsu) Company Information
13.14.2 YC Biotech (Jiangsu) Mesalamine Product Portfolios and Specifications
13.14.3 YC Biotech (Jiangsu) Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 YC Biotech (Jiangsu) Main Business Overview
13.14.5 YC Biotech (Jiangsu) Latest Developments
13.15 Xinxiang Tianfeng Fine Chemical
13.15.1 Xinxiang Tianfeng Fine Chemical Company Information
13.15.2 Xinxiang Tianfeng Fine Chemical Mesalamine Product Portfolios and Specifications
13.15.3 Xinxiang Tianfeng Fine Chemical Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Xinxiang Tianfeng Fine Chemical Main Business Overview
13.15.5 Xinxiang Tianfeng Fine Chemical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Mesalamine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Mesalamine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Purity ? 97%
Table 4. Major Players of Purity ? 98%
Table 5. Major Players of Purity ? 99%
Table 6. Global Mesalamine Sales byType (2020-2025) & (Tons)
Table 7. Global Mesalamine Sales Market Share byType (2020-2025)
Table 8. Global Mesalamine Revenue byType (2020-2025) & ($ million)
Table 9. Global Mesalamine Revenue Market Share byType (2020-2025)
Table 10. Global Mesalamine Sale Price byType (2020-2025) & (US$/kg)
Table 11. Global Mesalamine Sale by Application (2020-2025) & (Tons)
Table 12. Global Mesalamine Sale Market Share by Application (2020-2025)
Table 13. Global Mesalamine Revenue by Application (2020-2025) & ($ million)
Table 14. Global Mesalamine Revenue Market Share by Application (2020-2025)
Table 15. Global Mesalamine Sale Price by Application (2020-2025) & (US$/kg)
Table 16. Global Mesalamine Sales by Company (2020-2025) & (Tons)
Table 17. Global Mesalamine Sales Market Share by Company (2020-2025)
Table 18. Global Mesalamine Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Mesalamine Revenue Market Share by Company (2020-2025)
Table 20. Global Mesalamine Sale Price by Company (2020-2025) & (US$/kg)
Table 21. Key Manufacturers Mesalamine Producing Area Distribution and Sales Area
Table 22. Players Mesalamine Products Offered
Table 23. Mesalamine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Mesalamine Sales by Geographic Region (2020-2025) & (Tons)
Table 27. Global Mesalamine Sales Market Share Geographic Region (2020-2025)
Table 28. Global Mesalamine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Mesalamine Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Mesalamine Sales by Country/Region (2020-2025) & (Tons)
Table 31. Global Mesalamine Sales Market Share by Country/Region (2020-2025)
Table 32. Global Mesalamine Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Mesalamine Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Mesalamine Sales by Country (2020-2025) & (Tons)
Table 35. Americas Mesalamine Sales Market Share by Country (2020-2025)
Table 36. Americas Mesalamine Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Mesalamine Sales byType (2020-2025) & (Tons)
Table 38. Americas Mesalamine Sales by Application (2020-2025) & (Tons)
Table 39. APAC Mesalamine Sales by Region (2020-2025) & (Tons)
Table 40. APAC Mesalamine Sales Market Share by Region (2020-2025)
Table 41. APAC Mesalamine Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Mesalamine Sales byType (2020-2025) & (Tons)
Table 43. APAC Mesalamine Sales by Application (2020-2025) & (Tons)
Table 44. Europe Mesalamine Sales by Country (2020-2025) & (Tons)
Table 45. Europe Mesalamine Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Mesalamine Sales byType (2020-2025) & (Tons)
Table 47. Europe Mesalamine Sales by Application (2020-2025) & (Tons)
Table 48. Middle East & Africa Mesalamine Sales by Country (2020-2025) & (Tons)
Table 49. Middle East & Africa Mesalamine Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Mesalamine Sales byType (2020-2025) & (Tons)
Table 51. Middle East & Africa Mesalamine Sales by Application (2020-2025) & (Tons)
Table 52. Key Market Drivers & Growth Opportunities of Mesalamine
Table 53. Key Market Challenges & Risks of Mesalamine
Table 54. Key IndustryTrends of Mesalamine
Table 55. Mesalamine Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Mesalamine Distributors List
Table 58. Mesalamine Customer List
Table 59. Global Mesalamine SalesForecast by Region (2026-2031) & (Tons)
Table 60. Global Mesalamine RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Mesalamine SalesForecast by Country (2026-2031) & (Tons)
Table 62. Americas Mesalamine Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Mesalamine SalesForecast by Region (2026-2031) & (Tons)
Table 64. APAC Mesalamine Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Mesalamine SalesForecast by Country (2026-2031) & (Tons)
Table 66. Europe Mesalamine RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Mesalamine SalesForecast by Country (2026-2031) & (Tons)
Table 68. Middle East & Africa Mesalamine RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Mesalamine SalesForecast byType (2026-2031) & (Tons)
Table 70. Global Mesalamine RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Mesalamine SalesForecast by Application (2026-2031) & (Tons)
Table 72. Global Mesalamine RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. PharmaZell Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 74. PharmaZell Mesalamine Product Portfolios and Specifications
Table 75. PharmaZell Mesalamine Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 76. PharmaZell Main Business
Table 77. PharmaZell Latest Developments
Table 78. Syntese A/S Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 79. Syntese A/S Mesalamine Product Portfolios and Specifications
Table 80. Syntese A/S Mesalamine Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 81. Syntese A/S Main Business
Table 82. Syntese A/S Latest Developments
Table 83. Cambrex Corporation Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 84. Cambrex Corporation Mesalamine Product Portfolios and Specifications
Table 85. Cambrex Corporation Mesalamine Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 86. Cambrex Corporation Main Business
Table 87. Cambrex Corporation Latest Developments
Table 88. Divis Laboratories Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 89. Divis Laboratories Mesalamine Product Portfolios and Specifications
Table 90. Divis Laboratories Mesalamine Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 91. Divis Laboratories Main Business
Table 92. Divis Laboratories Latest Developments
Table 93. Chemi SpA Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 94. Chemi SpA Mesalamine Product Portfolios and Specifications
Table 95. Chemi SpA Mesalamine Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 96. Chemi SpA Main Business
Table 97. Chemi SpA Latest Developments
Table 98. Ipca Laboratories Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 99. Ipca Laboratories Mesalamine Product Portfolios and Specifications
Table 100. Ipca Laboratories Mesalamine Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 101. Ipca Laboratories Main Business
Table 102. Ipca Laboratories Latest Developments
Table 103. Hangzhou Brother Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 104. Hangzhou Brother Mesalamine Product Portfolios and Specifications
Table 105. Hangzhou Brother Mesalamine Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 106. Hangzhou Brother Main Business
Table 107. Hangzhou Brother Latest Developments
Table 108. LianyungangFengheng Biopharm Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 109. LianyungangFengheng Biopharm Mesalamine Product Portfolios and Specifications
Table 110. LianyungangFengheng Biopharm Mesalamine Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 111. LianyungangFengheng Biopharm Main Business
Table 112. LianyungangFengheng Biopharm Latest Developments
Table 113. Lasa Loboratory Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 114. Lasa Loboratory Mesalamine Product Portfolios and Specifications
Table 115. Lasa Loboratory Mesalamine Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 116. Lasa Loboratory Main Business
Table 117. Lasa Loboratory Latest Developments
Table 118. Corden Pharma Bergamo Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 119. Corden Pharma Bergamo Mesalamine Product Portfolios and Specifications
Table 120. Corden Pharma Bergamo Mesalamine Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 121. Corden Pharma Bergamo Main Business
Table 122. Corden Pharma Bergamo Latest Developments
Table 123. Erregierre SpA Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 124. Erregierre SpA Mesalamine Product Portfolios and Specifications
Table 125. Erregierre SpA Mesalamine Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 126. Erregierre SpA Main Business
Table 127. Erregierre SpA Latest Developments
Table 128. CTX Lifescience Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 129. CTX Lifescience Mesalamine Product Portfolios and Specifications
Table 130. CTX Lifescience Mesalamine Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 131. CTX Lifescience Main Business
Table 132. CTX Lifescience Latest Developments
Table 133. Ishita Active Pharma Ingredients Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 134. Ishita Active Pharma Ingredients Mesalamine Product Portfolios and Specifications
Table 135. Ishita Active Pharma Ingredients Mesalamine Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 136. Ishita Active Pharma Ingredients Main Business
Table 137. Ishita Active Pharma Ingredients Latest Developments
Table 138. YC Biotech (Jiangsu) Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 139. YC Biotech (Jiangsu) Mesalamine Product Portfolios and Specifications
Table 140. YC Biotech (Jiangsu) Mesalamine Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 141. YC Biotech (Jiangsu) Main Business
Table 142. YC Biotech (Jiangsu) Latest Developments
Table 143. XinxiangTianfengFine Chemical Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 144. XinxiangTianfengFine Chemical Mesalamine Product Portfolios and Specifications
Table 145. XinxiangTianfengFine Chemical Mesalamine Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 146. XinxiangTianfengFine Chemical Main Business
Table 147. XinxiangTianfengFine Chemical Latest Developments
LIST OFFIGURES
Figure 1. Picture of Mesalamine
Figure 2. Mesalamine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mesalamine Sales Growth Rate 2020-2031 (Tons)
Figure 7. Global Mesalamine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Mesalamine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Mesalamine Sales Market Share by Country/Region (2024)
Figure 10. Mesalamine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Purity ? 97%
Figure 12. Product Picture of Purity ? 98%
Figure 13. Product Picture of Purity ? 99%
Figure 14. Global Mesalamine Sales Market Share byType in 2025
Figure 15. Global Mesalamine Revenue Market Share byType (2020-2025)
Figure 16. Mesalamine Consumed inTablets
Figure 17. Global Mesalamine Market:Tablets (2020-2025) & (Tons)
Figure 18. Mesalamine Consumed in Capsules
Figure 19. Global Mesalamine Market: Capsules (2020-2025) & (Tons)
Figure 20. Mesalamine Consumed in Granule
Figure 21. Global Mesalamine Market: Granule (2020-2025) & (Tons)
Figure 22. Mesalamine Consumed in Suppository
Figure 23. Global Mesalamine Market: Suppository (2020-2025) & (Tons)
Figure 24. Mesalamine Consumed in Enema
Figure 25. Global Mesalamine Market: Enema (2020-2025) & (Tons)
Figure 26. Mesalamine Consumed in Others
Figure 27. Global Mesalamine Market: Others (2020-2025) & (Tons)
Figure 28. Global Mesalamine Sale Market Share by Application (2024)
Figure 29. Global Mesalamine Revenue Market Share by Application in 2025
Figure 30. Mesalamine Sales by Company in 2025 (Tons)
Figure 31. Global Mesalamine Sales Market Share by Company in 2025
Figure 32. Mesalamine Revenue by Company in 2025 ($ millions)
Figure 33. Global Mesalamine Revenue Market Share by Company in 2025
Figure 34. Global Mesalamine Sales Market Share by Geographic Region (2020-2025)
Figure 35. Global Mesalamine Revenue Market Share by Geographic Region in 2025
Figure 36. Americas Mesalamine Sales 2020-2025 (Tons)
Figure 37. Americas Mesalamine Revenue 2020-2025 ($ millions)
Figure 38. APAC Mesalamine Sales 2020-2025 (Tons)
Figure 39. APAC Mesalamine Revenue 2020-2025 ($ millions)
Figure 40. Europe Mesalamine Sales 2020-2025 (Tons)
Figure 41. Europe Mesalamine Revenue 2020-2025 ($ millions)
Figure 42. Middle East & Africa Mesalamine Sales 2020-2025 (Tons)
Figure 43. Middle East & Africa Mesalamine Revenue 2020-2025 ($ millions)
Figure 44. Americas Mesalamine Sales Market Share by Country in 2025
Figure 45. Americas Mesalamine Revenue Market Share by Country (2020-2025)
Figure 46. Americas Mesalamine Sales Market Share byType (2020-2025)
Figure 47. Americas Mesalamine Sales Market Share by Application (2020-2025)
Figure 48. United States Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 49. Canada Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 50. Mexico Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 51. Brazil Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 52. APAC Mesalamine Sales Market Share by Region in 2025
Figure 53. APAC Mesalamine Revenue Market Share by Region (2020-2025)
Figure 54. APAC Mesalamine Sales Market Share byType (2020-2025)
Figure 55. APAC Mesalamine Sales Market Share by Application (2020-2025)
Figure 56. China Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 57. Japan Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 58. South Korea Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 59. Southeast Asia Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 60. India Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 61. Australia Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 62. ChinaTaiwan Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 63. Europe Mesalamine Sales Market Share by Country in 2025
Figure 64. Europe Mesalamine Revenue Market Share by Country (2020-2025)
Figure 65. Europe Mesalamine Sales Market Share byType (2020-2025)
Figure 66. Europe Mesalamine Sales Market Share by Application (2020-2025)
Figure 67. Germany Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 68.France Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 69. UK Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 70. Italy Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 71. Russia Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 72. Middle East & Africa Mesalamine Sales Market Share by Country (2020-2025)
Figure 73. Middle East & Africa Mesalamine Sales Market Share byType (2020-2025)
Figure 74. Middle East & Africa Mesalamine Sales Market Share by Application (2020-2025)
Figure 75. Egypt Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 76. South Africa Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 77. Israel Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 78.Turkey Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 79. GCC Countries Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 80. Manufacturing Cost Structure Analysis of Mesalamine in 2025
Figure 81. Manufacturing Process Analysis of Mesalamine
Figure 82. Industry Chain Structure of Mesalamine
Figure 83. Channels of Distribution
Figure 84. Global Mesalamine Sales MarketForecast by Region (2026-2031)
Figure 85. Global Mesalamine Revenue Market ShareForecast by Region (2026-2031)
Figure 86. Global Mesalamine Sales Market ShareForecast byType (2026-2031)
Figure 87. Global Mesalamine Revenue Market ShareForecast byType (2026-2031)
Figure 88. Global Mesalamine Sales Market ShareForecast by Application (2026-2031)
Figure 89. Global Mesalamine Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Mesalamine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Mesalamine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Mesalamine by Country/Region, 2020, 2024 & 2031
2.2 Mesalamine Segment by Type
2.2.1 Purity ? 97%
2.2.2 Purity ? 98%
2.2.3 Purity ? 99%
2.3 Mesalamine Sales by Type
2.3.1 Global Mesalamine Sales Market Share by Type (2020-2025)
2.3.2 Global Mesalamine Revenue and Market Share by Type (2020-2025)
2.3.3 Global Mesalamine Sale Price by Type (2020-2025)
2.4 Mesalamine Segment by Application
2.4.1 Tablets
2.4.2 Capsules
2.4.3 Granule
2.4.4 Suppository
2.4.5 Enema
2.4.6 Others
2.5 Mesalamine Sales by Application
2.5.1 Global Mesalamine Sale Market Share by Application (2020-2025)
2.5.2 Global Mesalamine Revenue and Market Share by Application (2020-2025)
2.5.3 Global Mesalamine Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Mesalamine Breakdown Data by Company
3.1.1 Global Mesalamine Annual Sales by Company (2020-2025)
3.1.2 Global Mesalamine Sales Market Share by Company (2020-2025)
3.2 Global Mesalamine Annual Revenue by Company (2020-2025)
3.2.1 Global Mesalamine Revenue by Company (2020-2025)
3.2.2 Global Mesalamine Revenue Market Share by Company (2020-2025)
3.3 Global Mesalamine Sale Price by Company
3.4 Key Manufacturers Mesalamine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mesalamine Product Location Distribution
3.4.2 Players Mesalamine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MESALAMINE BY GEOGRAPHIC REGION
4.1 World Historic Mesalamine Market Size by Geographic Region (2020-2025)
4.1.1 Global Mesalamine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Mesalamine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Mesalamine Market Size by Country/Region (2020-2025)
4.2.1 Global Mesalamine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Mesalamine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Mesalamine Sales Growth
4.4 APAC Mesalamine Sales Growth
4.5 Europe Mesalamine Sales Growth
4.6 Middle East & Africa Mesalamine Sales Growth
5 AMERICAS
5.1 Americas Mesalamine Sales by Country
5.1.1 Americas Mesalamine Sales by Country (2020-2025)
5.1.2 Americas Mesalamine Revenue by Country (2020-2025)
5.2 Americas Mesalamine Sales by Type (2020-2025)
5.3 Americas Mesalamine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mesalamine Sales by Region
6.1.1 APAC Mesalamine Sales by Region (2020-2025)
6.1.2 APAC Mesalamine Revenue by Region (2020-2025)
6.2 APAC Mesalamine Sales by Type (2020-2025)
6.3 APAC Mesalamine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Mesalamine by Country
7.1.1 Europe Mesalamine Sales by Country (2020-2025)
7.1.2 Europe Mesalamine Revenue by Country (2020-2025)
7.2 Europe Mesalamine Sales by Type (2020-2025)
7.3 Europe Mesalamine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Mesalamine by Country
8.1.1 Middle East & Africa Mesalamine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Mesalamine Revenue by Country (2020-2025)
8.2 Middle East & Africa Mesalamine Sales by Type (2020-2025)
8.3 Middle East & Africa Mesalamine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mesalamine
10.3 Manufacturing Process Analysis of Mesalamine
10.4 Industry Chain Structure of Mesalamine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mesalamine Distributors
11.3 Mesalamine Customer
12 WORLD FORECAST REVIEW FOR MESALAMINE BY GEOGRAPHIC REGION
12.1 Global Mesalamine Market Size Forecast by Region
12.1.1 Global Mesalamine Forecast by Region (2026-2031)
12.1.2 Global Mesalamine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Mesalamine Forecast by Type (2026-2031)
12.7 Global Mesalamine Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 PharmaZell
13.1.1 PharmaZell Company Information
13.1.2 PharmaZell Mesalamine Product Portfolios and Specifications
13.1.3 PharmaZell Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 PharmaZell Main Business Overview
13.1.5 PharmaZell Latest Developments
13.2 Syntese A/S
13.2.1 Syntese A/S Company Information
13.2.2 Syntese A/S Mesalamine Product Portfolios and Specifications
13.2.3 Syntese A/S Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Syntese A/S Main Business Overview
13.2.5 Syntese A/S Latest Developments
13.3 Cambrex Corporation
13.3.1 Cambrex Corporation Company Information
13.3.2 Cambrex Corporation Mesalamine Product Portfolios and Specifications
13.3.3 Cambrex Corporation Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Cambrex Corporation Main Business Overview
13.3.5 Cambrex Corporation Latest Developments
13.4 Divis Laboratories
13.4.1 Divis Laboratories Company Information
13.4.2 Divis Laboratories Mesalamine Product Portfolios and Specifications
13.4.3 Divis Laboratories Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Divis Laboratories Main Business Overview
13.4.5 Divis Laboratories Latest Developments
13.5 Chemi SpA
13.5.1 Chemi SpA Company Information
13.5.2 Chemi SpA Mesalamine Product Portfolios and Specifications
13.5.3 Chemi SpA Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Chemi SpA Main Business Overview
13.5.5 Chemi SpA Latest Developments
13.6 Ipca Laboratories
13.6.1 Ipca Laboratories Company Information
13.6.2 Ipca Laboratories Mesalamine Product Portfolios and Specifications
13.6.3 Ipca Laboratories Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Ipca Laboratories Main Business Overview
13.6.5 Ipca Laboratories Latest Developments
13.7 Hangzhou Brother
13.7.1 Hangzhou Brother Company Information
13.7.2 Hangzhou Brother Mesalamine Product Portfolios and Specifications
13.7.3 Hangzhou Brother Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Hangzhou Brother Main Business Overview
13.7.5 Hangzhou Brother Latest Developments
13.8 Lianyungang Fengheng Biopharm
13.8.1 Lianyungang Fengheng Biopharm Company Information
13.8.2 Lianyungang Fengheng Biopharm Mesalamine Product Portfolios and Specifications
13.8.3 Lianyungang Fengheng Biopharm Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Lianyungang Fengheng Biopharm Main Business Overview
13.8.5 Lianyungang Fengheng Biopharm Latest Developments
13.9 Lasa Loboratory
13.9.1 Lasa Loboratory Company Information
13.9.2 Lasa Loboratory Mesalamine Product Portfolios and Specifications
13.9.3 Lasa Loboratory Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Lasa Loboratory Main Business Overview
13.9.5 Lasa Loboratory Latest Developments
13.10 Corden Pharma Bergamo
13.10.1 Corden Pharma Bergamo Company Information
13.10.2 Corden Pharma Bergamo Mesalamine Product Portfolios and Specifications
13.10.3 Corden Pharma Bergamo Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Corden Pharma Bergamo Main Business Overview
13.10.5 Corden Pharma Bergamo Latest Developments
13.11 Erregierre SpA
13.11.1 Erregierre SpA Company Information
13.11.2 Erregierre SpA Mesalamine Product Portfolios and Specifications
13.11.3 Erregierre SpA Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Erregierre SpA Main Business Overview
13.11.5 Erregierre SpA Latest Developments
13.12 CTX Lifescience
13.12.1 CTX Lifescience Company Information
13.12.2 CTX Lifescience Mesalamine Product Portfolios and Specifications
13.12.3 CTX Lifescience Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 CTX Lifescience Main Business Overview
13.12.5 CTX Lifescience Latest Developments
13.13 Ishita Active Pharma Ingredients
13.13.1 Ishita Active Pharma Ingredients Company Information
13.13.2 Ishita Active Pharma Ingredients Mesalamine Product Portfolios and Specifications
13.13.3 Ishita Active Pharma Ingredients Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Ishita Active Pharma Ingredients Main Business Overview
13.13.5 Ishita Active Pharma Ingredients Latest Developments
13.14 YC Biotech (Jiangsu)
13.14.1 YC Biotech (Jiangsu) Company Information
13.14.2 YC Biotech (Jiangsu) Mesalamine Product Portfolios and Specifications
13.14.3 YC Biotech (Jiangsu) Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 YC Biotech (Jiangsu) Main Business Overview
13.14.5 YC Biotech (Jiangsu) Latest Developments
13.15 Xinxiang Tianfeng Fine Chemical
13.15.1 Xinxiang Tianfeng Fine Chemical Company Information
13.15.2 Xinxiang Tianfeng Fine Chemical Mesalamine Product Portfolios and Specifications
13.15.3 Xinxiang Tianfeng Fine Chemical Mesalamine Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Xinxiang Tianfeng Fine Chemical Main Business Overview
13.15.5 Xinxiang Tianfeng Fine Chemical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Mesalamine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Mesalamine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Purity ? 97%
Table 4. Major Players of Purity ? 98%
Table 5. Major Players of Purity ? 99%
Table 6. Global Mesalamine Sales byType (2020-2025) & (Tons)
Table 7. Global Mesalamine Sales Market Share byType (2020-2025)
Table 8. Global Mesalamine Revenue byType (2020-2025) & ($ million)
Table 9. Global Mesalamine Revenue Market Share byType (2020-2025)
Table 10. Global Mesalamine Sale Price byType (2020-2025) & (US$/kg)
Table 11. Global Mesalamine Sale by Application (2020-2025) & (Tons)
Table 12. Global Mesalamine Sale Market Share by Application (2020-2025)
Table 13. Global Mesalamine Revenue by Application (2020-2025) & ($ million)
Table 14. Global Mesalamine Revenue Market Share by Application (2020-2025)
Table 15. Global Mesalamine Sale Price by Application (2020-2025) & (US$/kg)
Table 16. Global Mesalamine Sales by Company (2020-2025) & (Tons)
Table 17. Global Mesalamine Sales Market Share by Company (2020-2025)
Table 18. Global Mesalamine Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Mesalamine Revenue Market Share by Company (2020-2025)
Table 20. Global Mesalamine Sale Price by Company (2020-2025) & (US$/kg)
Table 21. Key Manufacturers Mesalamine Producing Area Distribution and Sales Area
Table 22. Players Mesalamine Products Offered
Table 23. Mesalamine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Mesalamine Sales by Geographic Region (2020-2025) & (Tons)
Table 27. Global Mesalamine Sales Market Share Geographic Region (2020-2025)
Table 28. Global Mesalamine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Mesalamine Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Mesalamine Sales by Country/Region (2020-2025) & (Tons)
Table 31. Global Mesalamine Sales Market Share by Country/Region (2020-2025)
Table 32. Global Mesalamine Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Mesalamine Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Mesalamine Sales by Country (2020-2025) & (Tons)
Table 35. Americas Mesalamine Sales Market Share by Country (2020-2025)
Table 36. Americas Mesalamine Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Mesalamine Sales byType (2020-2025) & (Tons)
Table 38. Americas Mesalamine Sales by Application (2020-2025) & (Tons)
Table 39. APAC Mesalamine Sales by Region (2020-2025) & (Tons)
Table 40. APAC Mesalamine Sales Market Share by Region (2020-2025)
Table 41. APAC Mesalamine Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Mesalamine Sales byType (2020-2025) & (Tons)
Table 43. APAC Mesalamine Sales by Application (2020-2025) & (Tons)
Table 44. Europe Mesalamine Sales by Country (2020-2025) & (Tons)
Table 45. Europe Mesalamine Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Mesalamine Sales byType (2020-2025) & (Tons)
Table 47. Europe Mesalamine Sales by Application (2020-2025) & (Tons)
Table 48. Middle East & Africa Mesalamine Sales by Country (2020-2025) & (Tons)
Table 49. Middle East & Africa Mesalamine Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Mesalamine Sales byType (2020-2025) & (Tons)
Table 51. Middle East & Africa Mesalamine Sales by Application (2020-2025) & (Tons)
Table 52. Key Market Drivers & Growth Opportunities of Mesalamine
Table 53. Key Market Challenges & Risks of Mesalamine
Table 54. Key IndustryTrends of Mesalamine
Table 55. Mesalamine Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Mesalamine Distributors List
Table 58. Mesalamine Customer List
Table 59. Global Mesalamine SalesForecast by Region (2026-2031) & (Tons)
Table 60. Global Mesalamine RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Mesalamine SalesForecast by Country (2026-2031) & (Tons)
Table 62. Americas Mesalamine Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Mesalamine SalesForecast by Region (2026-2031) & (Tons)
Table 64. APAC Mesalamine Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Mesalamine SalesForecast by Country (2026-2031) & (Tons)
Table 66. Europe Mesalamine RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Mesalamine SalesForecast by Country (2026-2031) & (Tons)
Table 68. Middle East & Africa Mesalamine RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Mesalamine SalesForecast byType (2026-2031) & (Tons)
Table 70. Global Mesalamine RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Mesalamine SalesForecast by Application (2026-2031) & (Tons)
Table 72. Global Mesalamine RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. PharmaZell Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 74. PharmaZell Mesalamine Product Portfolios and Specifications
Table 75. PharmaZell Mesalamine Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 76. PharmaZell Main Business
Table 77. PharmaZell Latest Developments
Table 78. Syntese A/S Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 79. Syntese A/S Mesalamine Product Portfolios and Specifications
Table 80. Syntese A/S Mesalamine Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 81. Syntese A/S Main Business
Table 82. Syntese A/S Latest Developments
Table 83. Cambrex Corporation Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 84. Cambrex Corporation Mesalamine Product Portfolios and Specifications
Table 85. Cambrex Corporation Mesalamine Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 86. Cambrex Corporation Main Business
Table 87. Cambrex Corporation Latest Developments
Table 88. Divis Laboratories Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 89. Divis Laboratories Mesalamine Product Portfolios and Specifications
Table 90. Divis Laboratories Mesalamine Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 91. Divis Laboratories Main Business
Table 92. Divis Laboratories Latest Developments
Table 93. Chemi SpA Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 94. Chemi SpA Mesalamine Product Portfolios and Specifications
Table 95. Chemi SpA Mesalamine Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 96. Chemi SpA Main Business
Table 97. Chemi SpA Latest Developments
Table 98. Ipca Laboratories Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 99. Ipca Laboratories Mesalamine Product Portfolios and Specifications
Table 100. Ipca Laboratories Mesalamine Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 101. Ipca Laboratories Main Business
Table 102. Ipca Laboratories Latest Developments
Table 103. Hangzhou Brother Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 104. Hangzhou Brother Mesalamine Product Portfolios and Specifications
Table 105. Hangzhou Brother Mesalamine Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 106. Hangzhou Brother Main Business
Table 107. Hangzhou Brother Latest Developments
Table 108. LianyungangFengheng Biopharm Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 109. LianyungangFengheng Biopharm Mesalamine Product Portfolios and Specifications
Table 110. LianyungangFengheng Biopharm Mesalamine Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 111. LianyungangFengheng Biopharm Main Business
Table 112. LianyungangFengheng Biopharm Latest Developments
Table 113. Lasa Loboratory Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 114. Lasa Loboratory Mesalamine Product Portfolios and Specifications
Table 115. Lasa Loboratory Mesalamine Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 116. Lasa Loboratory Main Business
Table 117. Lasa Loboratory Latest Developments
Table 118. Corden Pharma Bergamo Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 119. Corden Pharma Bergamo Mesalamine Product Portfolios and Specifications
Table 120. Corden Pharma Bergamo Mesalamine Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 121. Corden Pharma Bergamo Main Business
Table 122. Corden Pharma Bergamo Latest Developments
Table 123. Erregierre SpA Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 124. Erregierre SpA Mesalamine Product Portfolios and Specifications
Table 125. Erregierre SpA Mesalamine Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 126. Erregierre SpA Main Business
Table 127. Erregierre SpA Latest Developments
Table 128. CTX Lifescience Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 129. CTX Lifescience Mesalamine Product Portfolios and Specifications
Table 130. CTX Lifescience Mesalamine Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 131. CTX Lifescience Main Business
Table 132. CTX Lifescience Latest Developments
Table 133. Ishita Active Pharma Ingredients Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 134. Ishita Active Pharma Ingredients Mesalamine Product Portfolios and Specifications
Table 135. Ishita Active Pharma Ingredients Mesalamine Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 136. Ishita Active Pharma Ingredients Main Business
Table 137. Ishita Active Pharma Ingredients Latest Developments
Table 138. YC Biotech (Jiangsu) Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 139. YC Biotech (Jiangsu) Mesalamine Product Portfolios and Specifications
Table 140. YC Biotech (Jiangsu) Mesalamine Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 141. YC Biotech (Jiangsu) Main Business
Table 142. YC Biotech (Jiangsu) Latest Developments
Table 143. XinxiangTianfengFine Chemical Basic Information, Mesalamine Manufacturing Base, Sales Area and Its Competitors
Table 144. XinxiangTianfengFine Chemical Mesalamine Product Portfolios and Specifications
Table 145. XinxiangTianfengFine Chemical Mesalamine Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 146. XinxiangTianfengFine Chemical Main Business
Table 147. XinxiangTianfengFine Chemical Latest Developments
LIST OFFIGURES
Figure 1. Picture of Mesalamine
Figure 2. Mesalamine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mesalamine Sales Growth Rate 2020-2031 (Tons)
Figure 7. Global Mesalamine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Mesalamine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Mesalamine Sales Market Share by Country/Region (2024)
Figure 10. Mesalamine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Purity ? 97%
Figure 12. Product Picture of Purity ? 98%
Figure 13. Product Picture of Purity ? 99%
Figure 14. Global Mesalamine Sales Market Share byType in 2025
Figure 15. Global Mesalamine Revenue Market Share byType (2020-2025)
Figure 16. Mesalamine Consumed inTablets
Figure 17. Global Mesalamine Market:Tablets (2020-2025) & (Tons)
Figure 18. Mesalamine Consumed in Capsules
Figure 19. Global Mesalamine Market: Capsules (2020-2025) & (Tons)
Figure 20. Mesalamine Consumed in Granule
Figure 21. Global Mesalamine Market: Granule (2020-2025) & (Tons)
Figure 22. Mesalamine Consumed in Suppository
Figure 23. Global Mesalamine Market: Suppository (2020-2025) & (Tons)
Figure 24. Mesalamine Consumed in Enema
Figure 25. Global Mesalamine Market: Enema (2020-2025) & (Tons)
Figure 26. Mesalamine Consumed in Others
Figure 27. Global Mesalamine Market: Others (2020-2025) & (Tons)
Figure 28. Global Mesalamine Sale Market Share by Application (2024)
Figure 29. Global Mesalamine Revenue Market Share by Application in 2025
Figure 30. Mesalamine Sales by Company in 2025 (Tons)
Figure 31. Global Mesalamine Sales Market Share by Company in 2025
Figure 32. Mesalamine Revenue by Company in 2025 ($ millions)
Figure 33. Global Mesalamine Revenue Market Share by Company in 2025
Figure 34. Global Mesalamine Sales Market Share by Geographic Region (2020-2025)
Figure 35. Global Mesalamine Revenue Market Share by Geographic Region in 2025
Figure 36. Americas Mesalamine Sales 2020-2025 (Tons)
Figure 37. Americas Mesalamine Revenue 2020-2025 ($ millions)
Figure 38. APAC Mesalamine Sales 2020-2025 (Tons)
Figure 39. APAC Mesalamine Revenue 2020-2025 ($ millions)
Figure 40. Europe Mesalamine Sales 2020-2025 (Tons)
Figure 41. Europe Mesalamine Revenue 2020-2025 ($ millions)
Figure 42. Middle East & Africa Mesalamine Sales 2020-2025 (Tons)
Figure 43. Middle East & Africa Mesalamine Revenue 2020-2025 ($ millions)
Figure 44. Americas Mesalamine Sales Market Share by Country in 2025
Figure 45. Americas Mesalamine Revenue Market Share by Country (2020-2025)
Figure 46. Americas Mesalamine Sales Market Share byType (2020-2025)
Figure 47. Americas Mesalamine Sales Market Share by Application (2020-2025)
Figure 48. United States Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 49. Canada Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 50. Mexico Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 51. Brazil Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 52. APAC Mesalamine Sales Market Share by Region in 2025
Figure 53. APAC Mesalamine Revenue Market Share by Region (2020-2025)
Figure 54. APAC Mesalamine Sales Market Share byType (2020-2025)
Figure 55. APAC Mesalamine Sales Market Share by Application (2020-2025)
Figure 56. China Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 57. Japan Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 58. South Korea Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 59. Southeast Asia Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 60. India Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 61. Australia Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 62. ChinaTaiwan Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 63. Europe Mesalamine Sales Market Share by Country in 2025
Figure 64. Europe Mesalamine Revenue Market Share by Country (2020-2025)
Figure 65. Europe Mesalamine Sales Market Share byType (2020-2025)
Figure 66. Europe Mesalamine Sales Market Share by Application (2020-2025)
Figure 67. Germany Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 68.France Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 69. UK Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 70. Italy Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 71. Russia Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 72. Middle East & Africa Mesalamine Sales Market Share by Country (2020-2025)
Figure 73. Middle East & Africa Mesalamine Sales Market Share byType (2020-2025)
Figure 74. Middle East & Africa Mesalamine Sales Market Share by Application (2020-2025)
Figure 75. Egypt Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 76. South Africa Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 77. Israel Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 78.Turkey Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 79. GCC Countries Mesalamine Revenue Growth 2020-2025 ($ millions)
Figure 80. Manufacturing Cost Structure Analysis of Mesalamine in 2025
Figure 81. Manufacturing Process Analysis of Mesalamine
Figure 82. Industry Chain Structure of Mesalamine
Figure 83. Channels of Distribution
Figure 84. Global Mesalamine Sales MarketForecast by Region (2026-2031)
Figure 85. Global Mesalamine Revenue Market ShareForecast by Region (2026-2031)
Figure 86. Global Mesalamine Sales Market ShareForecast byType (2026-2031)
Figure 87. Global Mesalamine Revenue Market ShareForecast byType (2026-2031)
Figure 88. Global Mesalamine Sales Market ShareForecast by Application (2026-2031)
Figure 89. Global Mesalamine Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Botulinum Toxin Injection Market Growth 2025-2031
US$ 3,660.00
October 2025
94 pages
Global Gold & Diamond Jewellery Market Growth (Status and Outlook) 2026-2032
US$ 3,660.00
July 2026
208 pages
